Head of Clinical Trials Regulatory Advisory Board
Daniel Vazquez is the former Senior Head Director, Global Regulatory Affairs Executive IQVIA (formerly Quintiles) for more than 20 years.
Daniel transformed the IQVIA organization into an industry leading CRO business and built a strong leadership team with a vision of becoming a highly focused Life Science and clinical trials specialty for biotech’s, pharmaceutical & medical device companies for their INDs, NDAs & clinical trial execution indications in all trial phases.
Mr. Vazquez currently serves as Head Manager of Regulatory Affairs for Latin America and Canada at Philip Morris International and President at eHealth Solutions, a consortium of clinical trials Life Sciences development.
In his advisory board role appointment will further the strength of ESTERN Medical leadership team and regulatory & scientific advisory board as our company focuses on global growth and expansion internationally.
Mr. Vazquez has an extensive track record of experience and will provide guidance for ESTERN strategic clinical trial research and development to support our sponsors, Biotech’s, Pharma & Medical Device Life Sciences industry companies.
Mr. Vazquez received his Pharmacist degree from the University of Buenos Aires in Argentina. He is internationally well recognized for his expertise & scientific publications in global strategic regulatory clinical research development in the biotech, pharmaceutical and medical device scientific community in some of the most prestigious life sciences academic institutions.
He has extensive publication track record and key member of diverse scientific organizations in the pharmaceutical & medical device industry, member, honorary founder and former president of the association of CROs (CAOIC) and member of the Clinical Trials Board of CAEME in Latin America.